Shenzhen, China

Anjin Tao

This inventor holds 5 USPTO granted patents and 3 published patent applications and 8 EPO patents. Top assignee: Hybio Pharmaceutical Co., Ltd.. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anjin Tao. Retrieved from https://idiyas.com/inventor/anjin-tao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Guangdong, CN (2019 - 2020)
  • Shenzhen, CN (2019 - 2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Anjin Tao: Innovator in Pharmaceutical Methods

Introduction

Anjin Tao is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His innovative methods focus on the purification and synthesis of complex peptides, which are crucial in drug development.

Latest Patents

One of Anjin Tao's latest patents is a "Method for Purifying Long Chain Polypeptide." This method involves a purification step that connects two chromatographic columns in series to effectively separate a crude product. The upstream column features a larger particle size than the downstream column. Additionally, the method includes a salt conversion step, where the target peak product is rinsed with a specific acetic acid aqueous solution and acetonitrile for desalination.

Another notable patent is the "Method for Synthesizing Etelcalcetide." This method outlines a solid-phase synthesis process for Etelcalcetide, which includes synthesizing the peptide resin and activating the sulfhydryl group of the Cys side chain. The process is designed to enhance yield and purity, significantly increasing the total yield of the refined peptide after purification.

Career Highlights

Anjin Tao is currently employed at Hybio Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing methods that improve the efficiency and effectiveness of peptide synthesis and purification.

Collaborations

Anjin collaborates with notable colleagues, including Jiancheng Yuan and Pengcheng Mi. Their combined expertise contributes to the innovative environment at Hybio Pharmaceutical Co., Ltd.

Conclusion

Anjin Tao's contributions to the field of pharmaceuticals through his innovative methods and patents highlight his role as a key inventor in the industry. His work not only advances scientific knowledge but also enhances the development of effective pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…